COMMANDER
Oral Rivaroxaban vs placebo for the prevention of CV events in chronic congestive HF subjects with significant obstructive CAD
- Stage
- klaar
- Medicine
- rivaroxaban
- Population
- ASCVD
- Phase
- III
- First Patient In
- 15 November 2013
- Last Patient In
- 27 July 2017
- Last Patient Last Visit
- 14 May 2018
Study Director
